These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34611216)

  • 21. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection.
    Kayongo A; Bartolomaeus TUP; Birkner T; Markó L; Löber U; Kigozi E; Atugonza C; Munana R; Mawanda D; Sekibira R; Uwimaana E; Alupo P; Kalyesubula R; Knauf F; Siddharthan T; Bagaya BS; Kateete DP; Joloba ML; Sewankambo NK; Jjingo D; Kirenga B; Checkley W; Forslund SK
    Microbiol Spectr; 2023 Feb; 11(2):e0213921. PubMed ID: 36790203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
    Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ;
    Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short term dynamics of the sputum microbiome among COPD patients.
    Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD
    PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
    López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
    Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
    Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
    PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiome diversity in the sputum of patients with pulmonary tuberculosis.
    Krishna P; Jain A; Bisen PS
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1205-10. PubMed ID: 27142586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
    Wu X; Wei X; Li X; Deng J; Zhang J
    Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
    Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.
    Tangedal S; Aanerud M; Grønseth R; Drengenes C; Wiker HG; Bakke PS; Eagan TM
    Respir Res; 2017 Aug; 18(1):164. PubMed ID: 28851370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease.
    Rofael SAD; Brown J; Lipman MCI; Lowe DM; Spratt D; Quaderi S; Hurst JR; McHugh TD
    BMJ Open Respir Res; 2023 Apr; 10(1):. PubMed ID: 37085283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.